Log in
Log in
Or log in with
GoogleGoogle
Twitter Twitter
Facebook Facebook
Apple Apple     
Sign up
Or log in with
GoogleGoogle
Twitter Twitter
Facebook Facebook
Apple Apple     
  1. Homepage
  2. Equities
  3. France
  4. Euronext Paris
  5. Cellectis S.A.
  6. News
  7. Summary
    ALCLS   FR0010425595

CELLECTIS S.A.

(ALCLS)
  Report
Real-time Euronext Paris  -  11:35 2022-10-04 am EDT
2.442 EUR   +5.35%
10/03Calyxt, Inc. : Entry into a Material Definitive Agreement, Other Events, Financial Statements and Exhibits (form 8-K)
AQ
09/29European ADRs Move Lower in Thursday Trading
MT
09/29Biopharmaceutical Group Cellectis Hires Chief Medical Officer
MT
SummaryQuotesChartsNewsRatingsCalendarCompanyFinancialsConsensusRevisionsFunds 
SummaryMost relevantAll NewsAnalyst Reco.Other languagesPress ReleasesOfficial PublicationsSector news

European ADRs Nudge Higher in Wednesday Trading

08/03/2022 | 11:12am EDT


© MT Newswires 2022
Stocks mentioned in the article
ChangeLast1st jan.
ADAPTIMMUNE THERAPEUTICS PLC 6.48% 1.15 Delayed Quote.-71.20%
AUTOLUS THERAPEUTICS PLC 25.69% 2.74 Delayed Quote.-58.00%
BICYCLE THERAPEUTICS PLC 2.27% 23.45 Delayed Quote.-61.48%
BIONTECH SE 0.65% 137.57 Delayed Quote.-46.98%
CELLECTIS S.A. 5.35% 2.442 Real-time Quote.-67.18%
DIAGEO PLC 2.27% 3791.5 Delayed Quote.-6.06%
ENDAVA PLC 1.76% 80.29 Delayed Quote.-52.19%
ERYTECH PHARMA S.A. 5.17% 0.61 Real-time Quote.-71.23%
GRIFOLS, S.A. 0.25% 9 Delayed Quote.-46.67%
GSK PLC 0.67% 1328.4 Delayed Quote.-19.18%
NATIONAL GRID PLC -0.21% 931.4 Delayed Quote.-12.12%
NOVO NORDISK A/S 1.58% 785.8 Delayed Quote.5.25%
S&P GSCI NATURAL GAS INDEX -0.70% 317.8669 Real-time Quote.74.53%
SEQUANS COMMUNICATIONS S.A. 11.21% 3.87 Delayed Quote.-26.58%
TELEFÓNICA, S.A. 0.78% 3.5 Delayed Quote.-9.14%
VODAFONE GROUP PLC 1.21% 104.98 Delayed Quote.-6.48%
ZEALAND PHARMA A/S -0.30% 167 Delayed Quote.15.44%
All news about CELLECTIS S.A.
10/03Calyxt, Inc. : Entry into a Material Definitive Agreement, Other Events, Financial Stateme..
AQ
09/29European ADRs Move Lower in Thursday Trading
MT
09/29Biopharmaceutical Group Cellectis Hires Chief Medical Officer
MT
09/28Cellectis Promotes Mark Frattini to Chief Medical Officer
MT
09/28Cellectis Appoints Mark Frattini, M.D., Ph.D. as Chief Medical Officer
GL
09/28Cellectis Appoints Mark Frattini as Chief Medical Officer
CI
09/28CELLECTIS S.A. : Changes in management and corporate officers
CO
09/27Cellectis S A : Document AMF CP. 2022E863159
PU
09/23European ADRs Fall in Friday Trading
MT
09/23Allogene Stocks Fall as Servier Abandons Anti-CD19 Partnership
AQ
More news
Analyst Recommendations on CELLECTIS S.A.
More recommendations
Financials
Sales 2022 39,2 M 39,1 M 39,1 M
Net income 2022 -100,0 M -99,6 M -99,6 M
Net Debt 2022 93,3 M 93,0 M 93,0 M
P/E ratio 2022 -0,65x
Yield 2022 -
Capitalization 111 M 111 M 111 M
EV / Sales 2022 5,21x
EV / Sales 2023 6,70x
Nbr of Employees 297
Free-Float 99,9%
Chart CELLECTIS S.A.
Duration : Period :
Cellectis S.A. Technical Analysis Chart | MarketScreener
Full-screen chart
Technical analysis trends CELLECTIS S.A.
Short TermMid-TermLong Term
TrendsBearishNeutralBearish
Income Statement Evolution
Consensus
Mean consensus -
Number of Analysts 0
Last Close Price 2,44
Average target price
Spread / Average Target -
EPS Revisions
Managers and Directors
André Choulika Chief Executive Officer & Director
Bing C. Wang Chief Financial Officer
Jean-Pierre Garnier Non-Executive Chairman
Philippe Duchateau Chief Scientific Officer
Mark Frattini Chief Medical Officer
Sector and Competitors
1st jan.Capi. (M$)
CELLECTIS S.A.-67.18%104
MODERNA, INC.-50.52%47 331
LONZA GROUP AG-35.56%36 715
IQVIA HOLDINGS INC.-31.56%34 728
SEAGEN INC.-9.98%25 397
ALNYLAM PHARMACEUTICALS, INC.16.05%23 620